Expert Rev Pharmacoecon Outcomes Res
April 2019
Introduction: During the last years, a significant number economic evaluations of HPV vaccination has been published. Given that cost-effectiveness constitutes an essential part of decision-making with regards to the reimbursement of a health technology, the purpose of this study is to provide a supportive tool to decision-makers regarding the economic efficiency of the introduction of HPV vaccination to national immunization programs.
Areas Covered: The PubMed database was searched in order to identify cost-effectiveness studies for HPV vaccination.